Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX

Frates James M sold 40,000 Amylyx Pharmaceuticals, Inc. shares (Form 4)

Traded Nov 9 to Nov 10, 2026 · Filed Nov 12, 2026

From Nov 9 to Nov 10, 2026, Frates James M (Chief Financial Officer) sold 40,000 Amylyx Pharmaceuticals, Inc. shares at an average US$30.19 for US$1.21M under a trading plan, leaving 233,625 shares. Filed Nov 12, 2026 (Form 4).

Sold
40,000 shares
Price
US$30.19 average (US$29.39 to US$30.97)
Value
US$1.21M
Holding after
233,625 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 9, 2026Common StockOption exercise20,000US$6.88253,625Direct
Nov 9, 2026Common StockSale7,700US$29.39245,925Direct
Nov 9, 2026Common StockSale12,300US$30.11233,625Direct
Nov 10, 2026Common StockOption exercise20,000US$6.88253,625Direct
Nov 10, 2026Common StockSale12,800US$30.32240,825Direct
Nov 10, 2026Common StockSale7,200US$30.97233,625Direct

Source

Download original · View original at SEC

Related